HCV Clinical Trials

65 clinical trials for HCV across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria — RECRUITING
• Appalachian Partnership to Reduce Disparities (Aim 2) — RECRUITING · NA
• A Setting Focus Overdose Prevention Intervention — RECRUITING · NA
• Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide — RECRUITING
• Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients — RECRUITING · NA
• Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis) — RECRUITING
• Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada — RECRUITING
• National Rapid TLC: Testing and Linkage to Care — NOT_YET_RECRUITING · NA
• The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City — ACTIVE_NOT_RECRUITING · NA
• Integrated HIV Prevention and HCV Care for PWID — ACTIVE_NOT_RECRUITING · NA
• Simplified HCV Integrated Management Model in Methadone Clinics in Ukraine — COMPLETED · NA
• Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior — COMPLETED
• HIV/HBV/HCV Triple Screening in Primary Care — NOT_YET_RECRUITING · NA
• Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland — NOT_YET_RECRUITING
• The South-East Asian Transgender Health Cohort — COMPLETED
• Facilitated Telemedicine in the Catholic Health System — NOT_YET_RECRUITING
• HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking — NOT_YET_RECRUITING · NA
• A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV — COMPLETED · PHASE2
• Community Intervention to Eliminate HCV Among People Who Use Drugs. — ACTIVE_NOT_RECRUITING · NA
• Hepatitis C Treatment in Probation and Parole Office — COMPLETED · NA
• Tools to Identify People At Risk or Already Infected with HIV and HCV — OTHER · NA
• Innovate, Involve, Inspire — NOT_YET_RECRUITING · NA
• Current Situation of Health Care in Women With HBV or HCV Infection — NOT_YET_RECRUITING
• Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System — COMPLETED
• Use of Blood Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma (HCC) — OTHER
• National Prisons Hepatitis Education Project: Research Evaluation — OTHER · NA
• Utilization of Hepatitis C Positive Kidneys in Negative Recipients — COMPLETED · PHASE2
• Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in HCV-infected Children — OTHER · PHASE3
• Effect of New Oral Treatment for Hepatitis C Virus on Seminal Parameters — COMPLETED · PHASE2
• Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and Long Covid Syndrome — NOT_YET_RECRUITING · PHASE2
• Alpha -1- Microglobulin (α1M) as an Early Biomarker in Renal Extrahepatic Manifestations of HCV-infection — OTHER
• Predictive Models of Hepatic Decompensation and Survival Outcomes in Pediatric Patients With Cirrhosis — OTHER
• HCV, HBV, HIV Testing During Consultation With Anesthesiologist — TERMINATED · NA
• Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt — COMPLETED · PHASE3
• Access Anti-HCV Assay European Union (EU) Clinical Trial Protocol — COMPLETED
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection — COMPLETED · PHASE3
• A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2) — COMPLETED · PHASE3
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 Infection — COMPLETED · PHASE2
• TD-6450 MAD Study in HCV Infected Subjects — COMPLETED · PHASE1
• Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet — WITHDRAWN · PHASE4
• Prognostic Model of HCV-related Disease Progression After DAAs — OTHER
• Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects. — COMPLETED · PHASE2
• Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects — COMPLETED · PHASE3
• Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease — WITHDRAWN
• Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs — OTHER
• Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease. — OTHER · PHASE4
• Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening — COMPLETED · NA
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures — TERMINATED · PHASE3
• Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases — OTHER
• A Clinical Trial of 16 Weeks of Duration to Evaluate Retreatment With Elbasvir/Grazoprevir Plus Sofosbuvir and Ribavirin in Patients With Chronic Hepatitis C Genotypes 1,4 Who Have Failed to Treat With a Regime Based on an Inhibitor of the NS5A — WITHDRAWN · PHASE4

Refine this search